CancerNet: a database for decoding multilevel molecular interactions across diverse cancer types

被引:25
|
作者
Meng, X. [1 ]
Wang, J. [1 ,2 ]
Yuan, C. [1 ]
Li, X. [1 ,2 ]
Zhou, Y. [1 ]
Hofestaedt, R. [3 ]
Chen, M. [1 ,2 ]
机构
[1] Zhejiang Univ, Coll Life Sci, Dept Bioinformat, Hangzhou 310058, Zhejiang, Peoples R China
[2] Zhejiang Univ, Inst Bioinformat, James D Watson Inst Genome Sci, Hangzhou 310058, Zhejiang, Peoples R China
[3] Univ Bielefeld, Fac Technol, Dept Bioinformat & Med Informat, D-33615 Bielefeld, Germany
来源
ONCOGENESIS | 2015年 / 4卷
关键词
MICRORNA REGULATORY NETWORK; TARGET PREDICTION; SYSTEMS BIOLOGY; DOWN-REGULATION; EXPRESSION; MIR-1; IDENTIFICATION; CELLS; MIRNA; RESOURCE;
D O I
10.1038/oncsis.2015.40
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Protein-protein interactions (PPIs) and microRNA (miRNA)-target interactions are important for deciphering the mechanisms of tumorigenesis. However, current PPI databases do not support cancer-specific analysis. Also, no available databases can be used to retrieve cancer-associated miRNA-target interactions. As the pathogenesis of human cancers is affected by several miRNAs rather than a single miRNA, it is needed to uncover miRNA synergism in a systems level. Here for each cancer type, we constructed a miRNA-miRNA functionally synergistic network based on the functions of miRNA targets and their topological features in that cancer PPI network. And for the first time, we report the cancer-specific database CancerNet (http://bis.zju.edu.cn/CancerNet), which contains information about PPIs, miRNA-target interactions and functionally synergistic miRNA-miRNA pairs across 33 human cancer types. In addition, PPI information across 33 main normal tissues and cell types are included. Flexible query methods are allowed to retrieve cancer molecular interactions. Network viewer can be used to visualize interactions that users are interested in. Enrichment analysis tool was designed to detect significantly overrepresented Gene Ontology categories of miRNA targets. Thus, CancerNet serves as a comprehensive platform for assessing the roles of proteins and miRNAs, as well as their interactions across human cancers.
引用
收藏
页码:e177 / e177
页数:7
相关论文
共 50 条
  • [21] NAVIGATING ANTIBODY-DRUG CONJUGATE TARGETS EXPRESSION PROFILES ACROSS DIVERSE PROSTATE CANCER TYPES
    Mulati, Yelin
    Fan, Yu
    Tian, Yuxuan
    Yao, Kaifeng
    Shen, Qi
    Yu, Wei
    Zhang, Qian
    He, Zhisong
    JOURNAL OF UROLOGY, 2024, 211 (05): : E896 - E896
  • [22] A minimal gene set characterizes TIL specific for diverse tumor antigens across different cancer types
    Zhen Zeng
    Tianbei Zhang
    Jiajia Zhang
    Shuai Li
    Sydney Connor
    Boyang Zhang
    Yimin Zhao
    Jordan Wilson
    Dipika Singh
    Rima Kulikauskas
    Candice D. Church
    Thomas H. Pulliam
    Saumya Jani
    Paul Nghiem
    Suzanne L. Topalian
    Patrick M. Forde
    Drew M. Pardoll
    Hongkai Ji
    Kellie N. Smith
    Nature Communications, 16 (1)
  • [23] Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesis
    Jing Wang
    Qi Liu
    Yu Shyr
    BMC Genomics, 16
  • [24] Decoding dynamic miRNA:ceRNA interactions unveils therapeutic insights and targets across predominant cancer landscapes
    Ari Yuka, Selcen
    Yilmaz, Alper
    BIODATA MINING, 2024, 17 (01)
  • [25] Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesis
    Wang, Jing
    Liu, Qi
    Shyr, Yu
    BMC GENOMICS, 2015, 16
  • [26] Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment
    Dalia Barkley
    Reuben Moncada
    Maayan Pour
    Deborah A. Liberman
    Ian Dryg
    Gregor Werba
    Wei Wang
    Maayan Baron
    Anjali Rao
    Bo Xia
    Gustavo S. França
    Alejandro Weil
    Deborah F. Delair
    Cristina Hajdu
    Amanda W. Lund
    Iman Osman
    Itai Yanai
    Nature Genetics, 2022, 54 : 1192 - 1201
  • [27] Drug Resistance-Related Competing Interactions of lncRNA and mRNA across 19 Cancer Types
    Liu, Haizhou
    Wang, Shuyuan
    Zhou, Shunheng
    Meng, Qianqian
    Ma, Xueyan
    Song, Xiaofeng
    Wang, Lihong
    Jiang, Wei
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 16 : 442 - 451
  • [28] Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment
    Barkley, Dalia
    Moncada, Reuben
    Pour, Maayan
    Liberman, Deborah A.
    Dryg, Ian
    Werba, Gregor
    Wang, Wei
    Baron, Maayan
    Rao, Anjali
    Xia, Bo
    Franca, Gustavo S.
    Weil, Alejandro
    Delair, Deborah F.
    Hajdu, Cristina
    Lund, Amanda W.
    Osman, Iman
    Yanai, Itai
    NATURE GENETICS, 2022, 54 (08) : 1192 - +
  • [29] Assessing visibility and bone changes of spinal metastases in CT scans: a comprehensive analysis across diverse cancer types
    Lee, Jung Oh
    Kim, Dong Hyun
    Chae, Hee-Dong
    Lee, Eugene
    Kang, Ji Hee
    Lee, Ji Hyun
    Kim, Hyo Jin
    Seo, Jiwoon
    Chai, Jee Won
    SKELETAL RADIOLOGY, 2024, 53 (08) : 1553 - 1561
  • [30] Inferences of individual drug responses across diverse cancer types using a novel competing endogenous RNA network
    Zhang, Yan
    Li, Xin
    Zhou, Dianshuang
    Zhi, Hui
    Wang, Peng
    Gao, Yue
    Guo, Maoni
    Yue, Ming
    Wang, Yanxia
    Shen, Weitao
    Ning, Shangwei
    Li, Yixue
    Li, Xia
    MOLECULAR ONCOLOGY, 2018, 12 (09) : 1429 - 1446